US 8012955
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
granted A61PA61P3/06A61P3/10
Quick answer
US patent 8012955 (N-substituted-heterocycloalkyloxybenzamide compounds and methods of use) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 70
- CPC classes
- A61P, A61P3/06, A61P3/10, A61P43/00, A61P9/00